Skip to content
Washington University School of Medicine in St. Louis

Hospital Medicine Virtual Journal Club

Menu
  • About
  • Archives
  • FAQs
  • How to Access Full-text Articles
  • How to Use
  • Privacy Policy and Terms of Use

Category: open forum infect dis

A Narrative Review of Early Oral Stepdown Therapy for the Treatment of Uncomplicated Staphylococcus aureus Bacteremia: Yay or Nay?

open forum infect dis • June 12, 2020

Adherence to Treatment Guideline Improves Patient Outcomes in a Prospective Cohort of Adults Hospitalized for Community-Acquired Pneumonia.

open forum infect dis • May 30, 2020

Post Hoc Assessment of Time to Clinical Response Among Adults Hospitalized with Community-Acquired Bacterial Pneumonia Who Received Either Lefamulin or Moxifloxacin in 2 Phase III Randomized, Double-Blind, Double-Dummy Clinical Trials.

open forum infect dis • May 29, 2020

C-Reactive Protein Level May Predict the Risk of COVID-19 Aggravation.

open forum infect dis • May 27, 2020

Low Sensitivity of Procalcitonin for Bacteremia at an Academic Medical Center: A Cautionary Tale for Antimicrobial Stewardship.

open forum infect dis • April 24, 2020

Telemedicine Infectious Diseases Consultations and Clinical Outcomes: A Systematic Review.

open forum infect dis • December 28, 2019

Impact of Procalcitonin Levels Combined with Active Intervention on Antimicrobial Stewardship in a Community Hospital.

open forum infect dis • August 11, 2019

Impact of Initial Antifungal Therapy on the Outcome of Patients With Candidemia and Septic Shock Admitted to Medical Wards: A Propensity Score-Adjusted Analysis.

open forum infect dis • July 24, 2019

Comparative Effectiveness of Exclusive Exposure to Nafcillin or Oxacillin, Cefazolin, Piperacillin/Tazobactam, and Fluoroquinolones Among a National Cohort of Veterans With Methicillin-Susceptible Staphylococcus aureus Bloodstream Infection.

open forum infect dis • July 10, 2019

Adverse Outcomes Associated With Potentially Inappropriate Antibiotic Use in Heart Failure Admissions.

open forum infect dis • June 19, 2019

Follow Us!

Follow Us on FacebookFollow Us on TwitterFollow Us on Instagram

Journal Club via Email

The HMVJC Minute Podcast

Subscribe Now!
  • AnchorAnchor
  • Apple PodcastsApple Podcasts
  • BreakerBreaker
  • Google PodcastsGoogle Podcasts
  • iHeartRadioiHeartRadio
  • PocketCastsPocketCasts
  • PodbayPodbay
  • Radio PublicRadio Public
  • SpotifySpotify
  • TikTokTikTok
  • YouTubeYouTube

Recent Comments

  • Anonymous on Things We Do for No Reason™: Obtaining Urine Testing in Older Adults With Delirium Without Signs or Symptoms of Urinary Tract Infection
  • agario unblocked on Outbreak caused by the SARS-CoV-2 Omicron variant in Norway, November to December 2021
  • Ronald M. Chavin on What about tocilizumab? A retrospective study from a NYC Hospital during the COVID-19 outbreak
  • An Examination of Ivermectin and Other Promising Medications in the Prevention and Treatment of COVID | Compounding Corner Pharmacy, Inc. on Montelukast in Hospitalized Patients Diagnosed with COVID-19
  • Nathan Martin on Effect of Antithrombotic Therapy on Clinical Outcomes in Outpatients With Clinically Stable Symptomatic COVID-19: The ACTIV-4B Randomized Clinical Trial

The HMVJC COVID Reading List

  • Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
  • Efficacy and Safety of Intensified Versus Standard Prophylactic Anticoagulation Therapy in Patients With Coronavirus Disease 2019: A Systematic Review and Meta-Analysis
  • Elevated D-dimer and Adverse In-hospital Outcomes in COVID-19 Patients and Synergism with Hyperglycemia
  • Occurrence and outcomes of possible superadded infections in older adults with COVID-19-cohort study
  • Comparison of the effect of intravenous dexamethasone and methylprednisolone on the treatment of hospitalized patients with COVID-19: A randomized clinical trial
  • Tixagevimab-cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial
  • Re-examining the widespread policy of stopping SGLT2 inhibitors during acute illness: A perspective based on the updated evidence
  • Tocilizumab Versus Baricitinib in Patients Hospitalized With COVID-19 Pneumonia and Hypoxemia: A Multicenter Retrospective Cohort Study
  • Neutralizing COVID-19 Convalescent Plasma in Adults Hospitalized with COVID-19: A Blinded Randomized Placebo-Controlled Trial
  • Ivermectin for preventing and treating COVID-19

Links

  • WU School of Medicine
  • Dept. of Medicine
  • Division of Hospital Medicine
  • Becker Medical Library
  • Society of Hospital Medicine
  • Today's Hospitalist

Editor: Robert J. Mahoney, M.D., CCS-P, SFHM

Powered by
PubMed

©2022 Washington University in St. Louis